- Home
- PTON vs IMVT Comparison
PTON vs IMVT Comparison
Compare PTON & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTON
- IMVT
- Stock Information
- Founded
- PTON 2012
- IMVT N/A
- Country
- PTON United States
- IMVT United States
- Employees
- PTON N/A
- IMVT N/A
- Industry
- PTON Recreational Games/Products/Toys
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PTON Consumer Discretionary
- IMVT Health Care
- Exchange
- PTON Nasdaq
- IMVT Nasdaq
- Market Cap
- PTON 2.7B
- IMVT 2.5B
- IPO Year
- PTON 2019
- IMVT N/A
- Fundamental
- Price
- PTON $6.16
- IMVT $14.14
- Analyst Decision
- PTON Buy
- IMVT Buy
- Analyst Count
- PTON 19
- IMVT 10
- Target Price
- PTON $7.72
- IMVT $40.14
- AVG Volume (30 Days)
- PTON 12.8M
- IMVT 1.4M
- Earning Date
- PTON 05-08-2025
- IMVT 05-28-2025
- Dividend Yield
- PTON N/A
- IMVT N/A
- EPS Growth
- PTON N/A
- IMVT N/A
- EPS
- PTON N/A
- IMVT N/A
- Revenue
- PTON $2,527,400,000.00
- IMVT N/A
- Revenue This Year
- PTON N/A
- IMVT $108.88
- Revenue Next Year
- PTON N/A
- IMVT N/A
- P/E Ratio
- PTON N/A
- IMVT N/A
- Revenue Growth
- PTON N/A
- IMVT N/A
- 52 Week Low
- PTON $2.83
- IMVT $12.72
- 52 Week High
- PTON $10.90
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- PTON 45.31
- IMVT 42.87
- Support Level
- PTON $5.82
- IMVT $13.36
- Resistance Level
- PTON $7.11
- IMVT $14.76
- Average True Range (ATR)
- PTON 0.43
- IMVT 0.89
- MACD
- PTON 0.04
- IMVT 0.05
- Stochastic Oscillator
- PTON 44.32
- IMVT 36.36
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of bike and tread and related accessories sales, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue is generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from the International markets.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).